Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.
about
DEAD-box RNA helicase Belle/DDX3 and the RNA interference pathway promote mitotic chromosome segregationRibavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominanceMicroRNA expression in hepatitis C virus-related malignancies: A brief reviewImpaired Replication of Hepatitis C Virus Containing Mutations in a Conserved NS5B Retinoblastoma Protein-Binding MotifRB tumor suppressive function in response to xenobiotic hepatocarcinogensmicroRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.Unique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control.Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinoma.RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1Leptin in hepatocellular carcinoma.A distinct first replication cycle of DNA introduced in mammalian cells.Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation.Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic mice.Hepatocellular carcinoma in Asia: Prevention strategy and planning.The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas.Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression.An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell CarcinomaHepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylationSystemic chromosome instability in Shugoshin-1 mice resulted in compromised glutathione pathway, activation of Wnt signaling and defects in immune system in the lungCyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular CarcinomaSurgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb.Emerging topics in human tumor virology.Animal models in the study of hepatitis C virus-associated liver pathologies.Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma.Genome guardian p53 and viral infections.Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection.Hepatitis B and C viruses and hepatocellular carcinoma.Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma.Charge neutralization as the major factor for the assembly of nucleocapsid-like particles from C-terminal truncated hepatitis C virus core protein.Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis.Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.Construction and identification of recombinant lentiviral vector containing HIV-1 Tat gene and its expression in 293T cells.Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events.Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway.The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA - effects on NS5B catalysis and allosteric inhibition.
P2860
Q24311316-1AF82CFF-E515-4CCD-987A-4D70C86820E9Q26777659-F431D500-CBB9-47AD-9CE2-7125400B6742Q26801181-604F417B-B2B2-4950-A8A3-2330A6B9F0D8Q27488885-3F81FD8B-7B4D-435C-A85C-3CEA3F0A4B0FQ28513539-2C1E6CE9-EE38-4DC8-A79B-463148F2DC08Q31141908-FA0E470A-7EE4-4C1E-A047-65AD740EF605Q33569618-66225B9A-4C83-466F-9589-C608D93C9B27Q33900599-53CE91A7-5513-44C1-8643-CD36B16F4B3AQ34298366-DE7E124D-0AA0-4548-8271-5DE59436E4E3Q34406436-410AB4DD-AA3E-4822-856D-EDB896616415Q34723884-2DE4E703-C9BE-49C6-82BE-B085525C52D3Q34765478-401B56A3-71D0-47EB-968C-D2140FC2CDB2Q35131908-133D908D-70C7-4737-AF21-CF4CD60D6E2AQ35284899-442E43A8-CD2A-4AB7-A96C-A4CB79E1F119Q35790424-9D9D29A2-1990-475F-8143-560A13510F2FQ35947249-D877601F-F552-414F-8898-C5DD6E2EE04BQ35954035-394BDEF9-0692-4BE2-B386-4A2EE0A5863FQ36177313-C1D7130B-0115-4AAD-89F7-000F57004133Q36294409-5EC99A7E-11C1-4A73-84A4-A54F2BD78F41Q37224290-FD8B8680-7934-4500-A015-F36DF4B13259Q37297666-02B28F2D-0C1E-4618-9810-BEE2DDF960D8Q37688118-880192B8-C729-4D8B-8F0E-8B60077DA970Q37858935-019597C5-74AE-4CB6-BB46-6A2063D9433CQ37886159-27C02216-37C3-41F7-86DB-8483F008DA20Q37891167-E6CF725B-9AE6-4C42-9DC2-1E448ED9B50AQ38068825-FBBE367C-AA49-404D-9353-159F584EAC9FQ38299880-52664DF5-D066-4B72-85D0-328EE9957362Q38615769-1B30E42F-A8E9-4580-9B26-012968702209Q39110553-E5BF1837-B0DD-4FFF-966D-906CBD657ABEQ39169949-5F8D43C7-7AC3-4AF6-83CF-6A397C327D24Q39523228-54E90D17-4158-481E-9189-B4A3CDAE48E9Q41053182-DD75436C-5E50-4B4C-A79A-4689A0ED2164Q41170298-8D0C10A8-2A14-44C9-B4DD-911C25E1FF89Q42288483-ACA70A31-56D4-47F8-A3A8-6FF3734A94BFQ42990432-B1BAB0AB-8B97-4948-A7FD-2E6C9822ED22Q43036140-05AF0A58-A30C-4B55-85DD-C100D1934034Q43137700-4EFB17BF-ADCB-4840-B8C4-CA29E22E62F6Q47098153-5043C2AD-2E56-4C6E-8989-E46C8E47C0D6
P2860
Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Tumor suppressors, chromosomal ...... virus-associated liver cancer.
@ast
Tumor suppressors, chromosomal ...... virus-associated liver cancer.
@en
type
label
Tumor suppressors, chromosomal ...... virus-associated liver cancer.
@ast
Tumor suppressors, chromosomal ...... virus-associated liver cancer.
@en
prefLabel
Tumor suppressors, chromosomal ...... virus-associated liver cancer.
@ast
Tumor suppressors, chromosomal ...... virus-associated liver cancer.
@en
P2860
P1476
Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer
@en
P2093
Stanley M Lemon
P2860
P304
P356
10.1146/ANNUREV.PATHOL.4.110807.092202
P577
2009-01-01T00:00:00Z